Zonisamide improves wearing‐off in Parkinson's disease: A randomized, double‐blind study

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|10|1343-1350

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.10, 2015-09, pp. : 1343-1350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa-related wearing-off in Parkinson's disease: identification and management

By Pahwa Rajesh   Lyons Kelly E.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 841-849

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double‐blind phase I/IIa study of intranasal glutathione in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 12, 2015-10 ,pp. : 1696-1701

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 1009-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double‐blind study

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 1, 2018-01 ,pp. : 169-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 329-332

John Wiley & Sons Inc

Access to resources Recommend Favorite